Premium Nahrungsergänzungsmittel | artgerecht

Autoimmune Markers – Definition, Types and Diagnosis

Autoimmune markers are blood test values that indicate autoimmune diseases. They help doctors detect misdirected immune responses early and initiate targeted treatment.

Regular tips about health Regular tips about health

Things worth knowing about "Autoimmune Markers"

Autoimmune markers are blood test values that indicate autoimmune diseases. They help doctors detect misdirected immune responses early and initiate targeted treatment.

What Are Autoimmune Markers?

Autoimmune markers are specific laboratory parameters measured in the blood that indicate a faulty immune response directed against the body´s own structures. In such cases, the immune system produces autoantibodies – antibodies that target the body´s own tissues, organs, or cells rather than external pathogens. Autoimmune markers are used in diagnostics to identify and classify autoimmune diseases and to monitor their progression over time.

Types of Autoimmune Markers

There is a wide range of autoimmune markers, which are tested depending on the suspected condition. The most important groups include:

ANA (Antinuclear Antibodies): Target components of the cell nucleus. Typical for systemic lupus erythematosus (SLE) and other connective tissue diseases.
Anti-dsDNA Antibodies: Highly specific for systemic lupus erythematosus.
Rheumatoid Factor (RF): Antibodies against the Fc portion of IgG antibodies; frequently detected in rheumatoid arthritis.
Anti-CCP Antibodies (ACPA): Highly specific for rheumatoid arthritis.
ANCA (Antineutrophil Cytoplasmic Antibodies): Relevant in vasculitides such as granulomatosis with polyangiitis.
TPO Antibodies and Anti-Tg Antibodies: Indicate autoimmune thyroid disease, e.g., Hashimoto thyroiditis.
Anti-Gliadin and Anti-Transglutaminase Antibodies: Used in the diagnosis of celiac disease.
AMA (Antimitochondrial Antibodies): Characteristic of primary biliary cholangitis (PBC).

When Are Autoimmune Markers Tested?

Autoimmune markers are measured when clinical symptoms or findings suggest an autoimmune condition. Common reasons for testing include:

Unexplained joint swelling, pain, or stiffness
Chronic fatigue without identifiable cause
Skin rashes, especially a butterfly-shaped rash on the face
Recurring organ inflammation (e.g., kidneys, liver, thyroid)
Abnormal blood counts or elevated inflammatory markers
Family history of autoimmune diseases

Diagnosis and Interpretation

A positive autoimmune marker alone is not sufficient to make a diagnosis. Many markers can also appear at low levels in healthy individuals. Interpretation always requires consideration of clinical symptoms, medical history, and additional laboratory findings. Key factors include the titer (concentration of the antibody), the pattern (e.g., in ANA testing via immunofluorescence), and the combination with other markers.

Titer and Clinical Relevance

Low titers (e.g., ANA 1:80) are often not clinically significant. High titers or specific antibody patterns greatly increase diagnostic value. An experienced physician – typically a rheumatologist, internist, or immunologist – interprets the results within the clinical context.

Treatment Following a Positive Result

Treatment is not based on the autoimmune marker itself but on the underlying disease. Common therapeutic approaches include:

Immunosuppressants (e.g., methotrexate, azathioprine): Suppress the overactive immune response.
Corticosteroids (e.g., prednisolone): Anti-inflammatory and immunosuppressive agents.
Biologics (e.g., TNF inhibitors, rituximab): Targeted interventions in the immune system for severe disease courses.
Hormone replacement therapy for thyroid autoimmune diseases (e.g., L-thyroxine for Hashimoto thyroiditis).
Gluten-free diet for celiac disease.

Monitoring and Follow-Up

Autoimmune markers are also used to monitor disease progression and treatment response. A decrease in antibody titers may indicate improvement, while an increase may suggest a flare-up or insufficient treatment.

References

German Society for Rheumatology (DGRh): Guidelines for the diagnosis of rheumatic diseases. www.dgrh.de
Mühlen C.A. von, Tan E.M. – Autoantibodies in the diagnosis of systemic rheumatic diseases. Seminars in Arthritis and Rheumatism, 1995; 24(5): 323-358.
World Health Organization (WHO): Autoimmune diseases – overview and management. www.who.int

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.